Ten workers at Amazon’s Coventry facility tested positive for non-contagious latent tuberculosis, prompting expanded ...
Researchers have developed an ingestible smart pill that activates only after reaching the stomach, confirming medication ...
Blocking Caspase-2 (the liver’s guardian enzyme) to treat fatty liver may produce chronic damage and multiply the risk of ...
A specific region in the brainstem causes high blood pressure. By targeting oxygen sensors in the neck, they can lower it ...
Recreational physical activity in adolescent girls is linked to healthier breast tissue and lower stress biomarkers, offering ...
High blood sugar levels after the meal contributes to 69% higher risk of Alzheimer’s disease and dementia. Controlling blood ...
EQT Life Sciences is pleased to announce that its LSP Dementia Fund has co-led a EUR 51 million Series B in Exciva (the "Company"), a clinical-stage biopharmaceutical company developing novel ...
Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) Chewable Tablets and VETMEDIN Solution ...
What is eosinophilic fasciitis, and how is it diagnosed and treated? Learn about this rare fascia condition in simple terms.
Vitamin B12 deficiency can cause anemia, nerve damage, cognitive changes, and mood symptoms. Experts warn it’s often missed, ...
Weight loss is not just physical; it is behavioural. Successful long-term weight control depends on habits that become ...
A selective Liver X Receptor inverse agonist lowered triglycerides and post-meal cholesterol in people, opening a safer path to treat hypertriglyceridemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results